Achilles Therapeutics (ACHL) Q2 2023 Earnings

Aug 4Confirmed
Nov 2022
Q4 2022
Q1 2023
Q2 2023
-0.61
-0.51
-0.42
-0.32

Details

Expected EPS
-0.42
Actual EPS
-0.42
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Achilles Therapeutics⁩ (⁦ACHL⁩) has reported earnings of ⁦-0.42⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts